Dermatology News and Research

Latest Dermatology News and Research

Combination of two topical creams can prevent cancer

A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin.

22 Mar 2019

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.

21 Mar 2019

Active substance from plant could turn into a ray of hope against eye tumors

An active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors.

20 Mar 2019

Skin diseases may be more prevalent than previously thought

Skin diseases are ranked as the fourth most common cause of human illness, but many affected people do not consult a physician. A new Journal of the European Academy of Dermatology and Venereology study estimates the prevalence of skin diseases outside the typical medical setting.

20 Mar 2019

Higher rates of anxiety and depression found among patients with atopic dermatitis

A British Journal of Dermatology study has found substantially higher rates of anxiety and depression among US adults with atopic dermatitis, compared to those without. The study also found that anxiety and depression often go undiagnosed in these individuals.

6 Mar 2019

New therapeutic approach for patients with pancreatic cancer

One-year survival is low among patients diagnosed with pancreatic cancer. Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have now come up with a potential new therapy for pancreatic cancer patients.

5 Mar 2019

Researchers identify common genetic signature among three rare skin diseases

A group of researchers lead by a lecturer from the Universidad Carlos III de Madrid, Marcela del Río, from the CIEMAT, the Rare Diseases Networking Biomedical Research Centre and Fundación Jiménez Díaz has identified a common genetic signature among three rare skin diseases or genodermatoses: recessive dystrophic epidermolysis bullosa, Kindler syndrome and xeroderma pigmentosum.

5 Mar 2019

New combinational drug therapy may effectively combat pancreatic cancer

Even among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progress has lagged behind that of many other malignancies.

5 Mar 2019

New therapeutic approach offers promise for patients with pancreatic cancer

Lustgarten Foundation and Stand Up To Cancer, strategic partners in the Pancreatic Cancer Collective, offer comments on research published today in the journal Nature Medicine which describes a new therapeutic approach with promise for patients with pancreatic cancer.

5 Mar 2019

Anti-rejection medications for kidney transplants linked to increased skin cancer risk

A study led by researchers at RCSI (Royal College of Surgeons in Ireland) has analyzed the pattern of skin cancer rates in kidney transplant patients, which suggests the increased risk is related to the anti-rejection medications.

27 Feb 2019

Scientists demonstrate key role of salt in allergic immune reactions

Salt apparently affects allergic immune reactions. A team working with Prof. Christina Zielinski at the Technical University of Munich has demonstrated in cell cultures that salt leads to the formation of Th2 cells.

21 Feb 2019

Greater primary care physician supply associated with longer life spans

New research shows us just how important primary care physicians are in prolonging our lives.

19 Feb 2019

Smoking may blight immune response against melanoma and reduce survival

Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked, according to a new report funded by Cancer Research UK.

18 Feb 2019

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

A Massachusetts General Hospital research team has identified interaction between two elements of the immune system as critical for the transformation of a protective immune response into chronic, cancer-promoting inflammation.

12 Feb 2019

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

11 Feb 2019